View Cart  

FFR-Guided PCI Outperforms Drug Therapy Over Two Years in FAME 2 Trial

The study shows FFR-guided PCI reduces rates of death, myocardial infarction and urgent revascularization in patients with stable heart disease. Read More

Zorvolex Approved by FDA for New Indication

The drug is now available for patients with osteoarthritis pain. Read More
The Solutions Center